AMGN ▲ +0.9% - Amgen Inc. $AMGN AMGEN: ASTHMA DRUG TEZSPIRE DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS; TEZSPIRE 210 MG & 420 MG ACHIEVED 64.8% & 68.9% HISTOLOGIC REMISSION AT WEEK 24 VS 3.5% PLACEBO IN CROSSING TRIAL 20-OCT-2026 09:02 AM ET